SmallCapTraders.com Proves Once Again to Be the Number One Source for Timely Small Cap Stock Picks
SmallCapTraders.com Proves Once Again to Be the Number One Source for Timely Small Cap Stock Picks
NEW YORK, NY--(Marketwired - Nov 5, 2013) - Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) is developing medical products that efficiently deliver oxygen to tissues in the body. The company has developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier called Oxycyte® that is currently in clinical and preclinical studies for intravenous delivery for indications such as traumatic brain injury, decompression sickness and stroke. The company is also developing PFC-based creams and gels for topical delivery to the skin for dermatologic conditions and potentially wound care. OXBT has led the market in price appreciation and volume this week. Read the news and get our updated initial report from 11-1-13 here: http://bit.ly/Report-OXBT
Stereotaxis, Inc. (NASDAQ: STXS) is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core Epoch™ Solution includes the Niobe® ES Remote Magnetic Navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables. The company has announced details and dates for its stock subscription rights. Another big winner for our members. Get the details and a full report at the link: http://bit.ly/Report--STXS
EnviroStar, Inc. (NYSEMKT: EVI) distributes commercial and industrial laundry equipment, dry cleaning equipment, and steam and hot waters boilers in the United States, the Caribbean, and Latin America. The company also supplies replacement parts and accessories, as well as provides maintenance services. It distributes commercial and industrial laundry equipment, such as washers and dryers, tunnel systems, and coin-operated machines; finishing equipment, including sheet feeders, flatwork ironers, automatic sheet folders, stackers, and rail systems, and hot water/steam systems; and dry cleaning machines comprising garment presses, finishing equipment, sorting and storage conveyors, and accessories and higher-end hotels. Get a full company report at the link: http://bit.ly/Report--EVI
Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States. The program consists of two components: Fresh Start Private has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates. Fresh Start Private also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results. Fresh Start Private's revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose. Read about how CEYY is revolutionizing the business of alcohol rehabilitation and get a full report at the link: http://bit.ly/Report--CEYY
For Small Cap Stock Alerts on the go send text keyword "smallcap" to 25827
Please note* that all media from Small-Cap Specialists LLC/SmallCapTraders.com is permission based. The companies mentioned in this media release have provided documented permission to Small-Cap Specialists LLC to use their company names and public ticker symbols for IR and unbiased research purposes. Small-Cap Specialists employees are not registered as an Investment Adviser in any jurisdiction whatsoever. This advertisement is for informational purposes only and is not intended to be a recommendation to buy or sell securities in any of the above mentioned companies. SCS LLC has NOT been compensated for the mention of any of the companies in this press release.
Contact:
Email Contact
Mark Bonacci
Chief Editor
SmallCapTraders.com Proves Once Again to Be the Number One Source for Timely Small Cap Stock Picks
NEW YORK, NY--(Marketwired - Nov 5, 2013) - Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) is developing medical products that efficiently deliver oxygen to tissues in the body. The company has developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier called Oxycyte® that is currently in clinical and preclinical studies for intravenous delivery for indications such as traumatic brain injury, decompression sickness and stroke. The company is also developing PFC-based creams and gels for topical delivery to the skin for dermatologic conditions and potentially wound care. OXBT has led the market in price appreciation and volume this week. Read the news and get our updated initial report from 11-1-13 here: http://bit.ly/Report-OXBT
Stereotaxis, Inc. (NASDAQ: STXS) is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core Epoch™ Solution includes the Niobe® ES Remote Magnetic Navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables. The company has announced details and dates for its stock subscription rights. Another big winner for our members. Get the details and a full report at the link: http://bit.ly/Report--STXS
EnviroStar, Inc. (NYSEMKT: EVI) distributes commercial and industrial laundry equipment, dry cleaning equipment, and steam and hot waters boilers in the United States, the Caribbean, and Latin America. The company also supplies replacement parts and accessories, as well as provides maintenance services. It distributes commercial and industrial laundry equipment, such as washers and dryers, tunnel systems, and coin-operated machines; finishing equipment, including sheet feeders, flatwork ironers, automatic sheet folders, stackers, and rail systems, and hot water/steam systems; and dry cleaning machines comprising garment presses, finishing equipment, sorting and storage conveyors, and accessories and higher-end hotels. Get a full company report at the link: http://bit.ly/Report--EVI
Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States. The program consists of two components: Fresh Start Private has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates. Fresh Start Private also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results. Fresh Start Private's revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose. Read about how CEYY is revolutionizing the business of alcohol rehabilitation and get a full report at the link: http://bit.ly/Report--CEYY
For Small Cap Stock Alerts on the go send text keyword "smallcap" to 25827
Please note* that all media from Small-Cap Specialists LLC/SmallCapTraders.com is permission based. The companies mentioned in this media release have provided documented permission to Small-Cap Specialists LLC to use their company names and public ticker symbols for IR and unbiased research purposes. Small-Cap Specialists employees are not registered as an Investment Adviser in any jurisdiction whatsoever. This advertisement is for informational purposes only and is not intended to be a recommendation to buy or sell securities in any of the above mentioned companies. SCS LLC has NOT been compensated for the mention of any of the companies in this press release.
Contact:
Email Contact
Mark Bonacci
Chief Editor
